Literature DB >> 8518410

Structural and functional studies of insulin receptors in human breast cancer.

L Frittitta1, R Vigneri, V Papa, I D Goldfine, G Grasso, V Trischitta.   

Abstract

We characterized the structure and the function of insulin receptors isolated from 10 human breast cancer specimens. We observed that the insulin receptor content, as determined by a specific radioimmunoassay, was four fold increased in human breast cancer tissue when compared to normal breast tissues. In both cancer and normal breast tissues, insulin receptor mRNA consisted of two major species of approximately 11.0 and 8.5 kilobases. The size of the insulin receptor alpha subunit was determined by 125I-insulin cross-linking followed by immunoprecipitation and polyacrylamide gel electrophoresis; a value of 135kDa was observed for receptors from both breast cancer and normal breast tissues. The functional binding ability of insulin receptors from cancer tissues was slightly lower as compared to normal tissue derived insulin receptor (% B/T = 2.22 +/- 0.50 per ng of insulin receptor as determined by radioimmunoassay vs. 2.96 +/- 0.49, mean +/- S.E.M.). The concentration of insulin that caused half maximal inhibition of 125I-insulin binding was very similar for both cancer and normal breast receptors (80pM). The size of the insulin receptor beta subunit as determined by receptor autophosphorylation was 95kDa. Basal and maximal insulin (100nM) stimulated receptor tyrosine kinase activity, in terms of both receptor autophosphorylation and phosphorylation of an exogenous substrate, was similar in malignant and normal breast tissue derived insulin receptor. Also, a very similar insulin stimulated Km value for ATP was showed by the tyrosine kinase of insulin receptors from breast cancer and normal breast tissue (11.1 and 10.8 microM ATP, respectively). However, in insulin receptors from breast cancer tissue the average tyrosine kinase sensitivity to insulin, as calculated on the exogenous substrate, was higher, although not significantly, with respect to normal breast tissue (ED50 at 0.28 +/- 0.09 and 1.08 +/- 0.33 nM insulin, respectively). A similarly different sensitivity to insulin was observed also for receptor autophosphorylation. In conclusion, this study demonstrates that breast cancer tissues have an increased number of structurally and functionally normal insulin receptors. In some breast cancer tissues, however, the sensitivity of the receptor tyrosine kinase activity to insulin is greatly increased. These data suggest that, in vivo, the mitogenic effect of insulin may play a role in the biology of certain breast cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518410     DOI: 10.1007/BF00662403

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

Review 1.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 2.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  Human insulin receptor radioimmunoassay: applicability to insulin-resistant states.

Authors:  V Pezzino; V Papa; V Trischitta; A Brunetti; P A Goodman; M K Treutelaar; J A Williams; B A Maddux; R Vigneri; I D Goldfine
Journal:  Am J Physiol       Date:  1989-09

5.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

6.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

7.  Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells.

Authors:  G Steele-Perkins; R A Roth
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

8.  Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase.

Authors:  D M Hawley; B A Maddux; R G Patel; K Y Wong; P W Mamula; G L Firestone; A Brunetti; E Verspohl; I D Goldfine
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

9.  Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype.

Authors:  F Giorgino; A Belfiore; G Milazzo; A Costantino; B Maddux; J Whittaker; I D Goldfine; R Vigneri
Journal:  Mol Endocrinol       Date:  1991-03

10.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

View more
  5 in total

Review 1.  Insulin receptors in breast cancer: biological and clinical role.

Authors:  V Papa; A Belfiore
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

Review 2.  Insulin, insulin receptors, and cancer.

Authors:  R Vigneri; I D Goldfine; L Frittitta
Journal:  J Endocrinol Invest       Date:  2016-07-01       Impact factor: 4.256

Review 3.  The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise.

Authors:  S Schmidt; J M Monk; L E Robinson; M Mourtzakis
Journal:  Obes Rev       Date:  2015-04-15       Impact factor: 9.213

4.  Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation.

Authors:  Veronica Vella; Maria Luisa Nicolosi; Marika Giuliano; Andrea Morrione; Roberta Malaguarnera; Antonino Belfiore
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

Review 5.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.